M Ventures

Portfolio Co Investors 2026 for M Ventures: investors, rounds, and co-investor patterns from StartupFundraising.com research, updated for 2026.

M Ventures accounts for 22 tracked companies with verified cap-table data, 22 of which disclose round sizes totalling $1.8B. The median disclosed raise is $65M, and the largest is Artios Pharma at $186M, ahead of Mosa Meat ($176M) and Legendairy Foods ($145M).

The names that recur most often on these co-invested cap tables are M Ventures (22 companies), Sofinnova Partners (5 companies), Novartis Venture Fund (4 companies), Omega Funds (3 companies), Pfizer Ventures (3 companies), Lowercarbon Capital (3 companies). By latest disclosed round, the market skews Series A (8), Series B (7), Series C (5), Seed (1).

Best funded M Ventures companies

  1. Artios Pharma — $186M (latest: Series C)
  2. Mosa Meat — $176M (latest: Series A)
  3. Legendairy Foods — $145M (latest: Series B)
  4. Storm Therapeutics — $126M (latest: Series C)
  5. IOmx Therapeutics — $125M (latest: Series B)
  6. Formo — $111M (latest: Series B)
  7. Asceneuron — $100M (latest: Series C)
  8. Nouscom — $97M (latest: Series C)
  9. NRG Therapeutics — $86M (latest: Series B)
  10. Actithera — $76M (latest: Series A)
  11. Neurable — $65M (latest: Series A)
  12. ReproNovo — $65M (latest: Series A)
  13. FoRx Therapeutics — $61M (latest: Series A)
  14. Carbonly — $61M (latest: Series B)
  15. Metalenz — $50M

M Ventures — related firms and companies (56)

M Ventures profile · All research reports